EP0796325A4 - Facteur de croissance vasculaire humain proche de la proteine de fixation du facteur de croissance insulinoide - Google Patents

Facteur de croissance vasculaire humain proche de la proteine de fixation du facteur de croissance insulinoide

Info

Publication number
EP0796325A4
EP0796325A4 EP95905378A EP95905378A EP0796325A4 EP 0796325 A4 EP0796325 A4 EP 0796325A4 EP 95905378 A EP95905378 A EP 95905378A EP 95905378 A EP95905378 A EP 95905378A EP 0796325 A4 EP0796325 A4 EP 0796325A4
Authority
EP
European Patent Office
Prior art keywords
growth factor
human vascular
vascular ibp
ibp
human
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP95905378A
Other languages
German (de)
English (en)
Other versions
EP0796325A1 (fr
Inventor
Gregg A Hastings
Craig A Rosen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Human Genome Sciences Inc
Original Assignee
Human Genome Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Genome Sciences Inc filed Critical Human Genome Sciences Inc
Publication of EP0796325A1 publication Critical patent/EP0796325A1/fr
Publication of EP0796325A4 publication Critical patent/EP0796325A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Diabetes (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP95905378A 1994-12-09 1994-12-09 Facteur de croissance vasculaire humain proche de la proteine de fixation du facteur de croissance insulinoide Withdrawn EP0796325A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1994/014388 WO1996017931A1 (fr) 1994-12-09 1994-12-09 Facteur de croissance vasculaire humain proche de la proteine de fixation du facteur de croissance insulinoide

Publications (2)

Publication Number Publication Date
EP0796325A1 EP0796325A1 (fr) 1997-09-24
EP0796325A4 true EP0796325A4 (fr) 1999-11-03

Family

ID=22243393

Family Applications (1)

Application Number Title Priority Date Filing Date
EP95905378A Withdrawn EP0796325A4 (fr) 1994-12-09 1994-12-09 Facteur de croissance vasculaire humain proche de la proteine de fixation du facteur de croissance insulinoide

Country Status (5)

Country Link
EP (1) EP0796325A4 (fr)
JP (1) JPH10510518A (fr)
AU (1) AU710568B2 (fr)
NZ (1) NZ278504A (fr)
WO (1) WO1996017931A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6670328B1 (en) * 1997-06-24 2003-12-30 Institut Pasteur De Lille Proteins and peptides derived from protein ESM-1 and their uses in the treatment and diagnosis of diseases linked to leukocyte migration
AU1273499A (en) * 1997-10-24 1999-05-17 Human Genome Sciences, Inc. 148 human secreted proteins
FR2775691B1 (fr) * 1998-03-05 2000-12-15 Pasteur Institut Anticorps monoclonaux specifiques de la proteine esm-1, et utilisation de ces anticorps pour la detection de la proteine esm-1
EP2792747A1 (fr) 2000-06-23 2014-10-22 Genentech, Inc. Compositions et procédés pour le traitement et le diagnostic des troubles impliquant une angiogenèse
EP2075253A1 (fr) 2000-06-23 2009-07-01 Genentech, Inc. Méthodes et composés pour la diagnose et le traitement de troubles associés à l'angiogenèse
FR2816214B1 (fr) * 2000-11-09 2005-10-21 Pasteur Institut Utilisation d'un compose antagoniste de la proteine esm-1 pour la fabrication d'un medicament pour la prevention et/ou le traitement d'un cancer
FR2816410B1 (fr) 2000-11-09 2003-04-18 Pasteur Institut Necessaire de detection de la proteine esm-1 et procede de detection mettant en oeuvre ledit necessaire

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992003471A1 (fr) * 1990-08-28 1992-03-05 Chiron Corporation Nouvelle proteine de liaison de facteur de croissance analogue a l'insuline igfbp-5
WO1992003152A1 (fr) * 1990-08-28 1992-03-05 Chiron Corporation Nouvelle proteine de liaison de facteur de croissance analogue a l'insuline (igfbp-4)
WO1992012243A1 (fr) * 1991-01-08 1992-07-23 Chiron Corporation Nouvelle proteine de fixation du facteur de croissance proche de l'insuline (igfbp-6)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2642656B1 (fr) * 1989-02-09 1991-11-15 Salomon Sa Fixation de securite pour ski destinee a maintenir l'avant d'une chaussure montee sur le ski

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992003471A1 (fr) * 1990-08-28 1992-03-05 Chiron Corporation Nouvelle proteine de liaison de facteur de croissance analogue a l'insuline igfbp-5
WO1992003152A1 (fr) * 1990-08-28 1992-03-05 Chiron Corporation Nouvelle proteine de liaison de facteur de croissance analogue a l'insuline (igfbp-4)
WO1992012243A1 (fr) * 1991-01-08 1992-07-23 Chiron Corporation Nouvelle proteine de fixation du facteur de croissance proche de l'insuline (igfbp-6)

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
BAR R.S. ET AL.: "Production of IGF-binding proteins by vascular endothelial cells", BIOCHEM. BIOPHYS. RES. COM., vol. 148, no. 2, 29 October 1987 (1987-10-29), pages 734 - 739, XP002114415 *
FORBES B. ET AL.: "Classification of the Insuline-like Growth Factor Binding Proteins into three distinct categories according to their binding specifities", BIOCHEM. BIOPHYS. RES. COM., vol. 157, no. 1, 30 November 1988 (1988-11-30), pages 196 - 202, XP002114416 *
See also references of WO9617931A1 *
SHIMASAKI S ET AL: "IDENTIFICATION OF FIVE DIFFERENT INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS (IGFBPS) FROM ADULT RAT SERUM AND MOLECULAR CLONING OF A NOVEL IGFBP-5 IN RAT AND HUMAN", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 266, no. 16, 5 June 1991 (1991-06-05), pages 10646 - 10653, XP000673586, ISSN: 0021-9258 *

Also Published As

Publication number Publication date
AU710568B2 (en) 1999-09-23
NZ278504A (en) 1999-10-28
AU1401495A (en) 1996-06-26
JPH10510518A (ja) 1998-10-13
WO1996017931A1 (fr) 1996-06-13
EP0796325A1 (fr) 1997-09-24

Similar Documents

Publication Publication Date Title
EP0871705A4 (fr) Facteur de croissance humain du type ccn
EP0741578A4 (fr) Hormone de croissance humaine
GB2301656B (en) Heart valve prosthesis
GB9317171D0 (en) Surgical implants etc
AU1683295A (en) Implantable vascular device
IL125756A0 (en) Catheter based surgery
NZ283716A (en) Bone growth stimulating factor
GB9510967D0 (en) Vascular prostheses
EP0929575A4 (fr) Nouveaux facteurs de croissance humains
EP0873348A4 (fr) Facteur de croissance 3 de l'endothelium vasculaire humain
GB9414157D0 (en) Medical use
EP0796325A4 (fr) Facteur de croissance vasculaire humain proche de la proteine de fixation du facteur de croissance insulinoide
GB9607201D0 (en) Medical article
EP0879240A4 (fr) Criptine humaine: facteur de croissance
GB9613010D0 (en) Medical article
EP0797592A4 (fr) Stanniocalcine-alpha humaine
GB9424232D0 (en) Growth factor expression
ZA947865B (en) Human glactokinase
EP0589819A3 (en) Elver-like artificial food
EP0795006A4 (fr) MutT2 HUMAIN
AU2700895A (en) Human vascular endothelial growth factor 3
GB9206282D0 (en) Vascular prosthesis
GB2297263B (en) Vascular prostheses
GB9513143D0 (en) Medical wig
HU9502355D0 (en) Human interleukin-6-inhibitor

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19970703

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 19990922

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20020716

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: HUMAN GENOME SCIENCES, INC.

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20120701